Sudair Pharmaceutical Company (SPC) is a Joint Stock Saudi company established in 2014, focused on building an Advanced Pharmaceutical Industrial Complex to address the unmet needs of the pharmaceutical market. The company is dedicated to providing high-quality biopharmaceuticals, generics, biosimilars, and licensed pharmaceutical products, aiming to enhance the healthcare landscape in Saudi Arabia and beyond.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Biologics
– Generics
– Biosimilars
– Licensing agreements

Sudair Pharmaceutical Company SPC continues to play a crucial role in the pharmaceutical industry, providing innovative solutions to meet the demands of healthcare providers and patients alike. For more information, visit sudairpharma.com.